<i>Commentary</i>: Benzodiazepine (BZD) and Related BZD-Receptor Agonists: Basic Science Reasons to Limit to Four Weeks or Less

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.org/journal/pp
E-mail: pp@scirp.org

Citations

"Commentary: Benzodiazepine (BZD) and Related BZD-Receptor Agonists: Basic Science Reasons to Limit to Four Weeks or Less"
written by Robert B. Raffa, Joseph V. Pergolizzi,
published by Pharmacology & Pharmacy, Vol.10 No.8, 2019

has been cited by the following article(s):

[1]	Pilot Studies on the Novel Hypothesis that TSPO (Peripheral Benzodiazepine Receptor) Is Involved in Benzodiazepine/“Z-Drug” Physical Dependence and/or …
	Pharmacology & …, 2023

[2]	Benzodiazepines: Thinking outside the black box
	2021

[3]	Benzodiazepine Withdrawal
	2020

[1]	Pilot Studies on the Novel Hypothesis that TSPO (Peripheral Benzodiazepine Receptor) Is Involved in Benzodiazepine/“Z-Drug” Physical Dependence and/or Withdrawal Pharmacology & Pharmacy, 2023 DOI:10.4236/pp.2023.143006

[2]	Benzodiazepines: Thinking outside the black box Journal of Clinical Pharmacy and Therapeutics, 2020 DOI:10.1111/jcpt.13333

[3]	The Benzodiazepines Crisis 2020 DOI:10.1093/med/9780197517277.003.0008

Top